Inactive Instrument

Highlights Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y1091

Highlights

Unlock all the news: Be the first to know and act before the market!

Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024	06-27	CI
Aethlon Medical, Inc. Receives Ethics Committee Approval for Hemopurifier® Cancer Trial	06-18	CI
Aethlon Medical, Inc. Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies	06-03	CI
Top Midday Decliners	05-15	MT
Aethlon Medical, Inc. Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma	05-10	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-14	CI
Aethlon Medical, Inc. Receives Clearance from Drug Controller General of India for Potential Phase 1 Trial of its Hemopurifier(R) in Oncology	23-10-10	CI
Reverse Split: 1 of 10	23-10-04	FA
Aethlon Medical Board Approves 1-for-10 Reverse Stock Split	23-10-04	MT
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-06-28	CI
Aethlon Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-13	CI
Aethlon Medical Taps Namsa to Manage Planned Clinical Trial of Medical Device for Cancer	23-01-30	MT
Aethlon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-14	CI
Aethlon Medical, Inc. Announces Early Feasibility Study of the Hemopurifier	22-09-29	CI
Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09	CI
Aethlon Medical, Inc. Announces U.S. FDA Approval of Hemopurifier COVID-19 Study Protocol Amendment	22-07-11	CI
Aethlon Medical Posts Wider Loss, Lower Revenue for Full-Year Fiscal 2022	22-06-28	MT
Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	22-06-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y1091

Highlights

Filters